Malebo, K.; Woodward, J.; Ximba, P.; Mkhize, Q.; Cingo, S.; Moyo-Gwete, T.; Moore, P.L.; Williamson, A.-L.; Chapman, R.
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies. Vaccines 2024, 12, 1063.
https://doi.org/10.3390/vaccines12091063
AMA Style
Malebo K, Woodward J, Ximba P, Mkhize Q, Cingo S, Moyo-Gwete T, Moore PL, Williamson A-L, Chapman R.
Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies. Vaccines. 2024; 12(9):1063.
https://doi.org/10.3390/vaccines12091063
Chicago/Turabian Style
Malebo, Kegomoditswe, Jeremy Woodward, Phindile Ximba, Qiniso Mkhize, Sanele Cingo, Thandeka Moyo-Gwete, Penny L. Moore, Anna-Lise Williamson, and Rosamund Chapman.
2024. "Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies" Vaccines 12, no. 9: 1063.
https://doi.org/10.3390/vaccines12091063
APA Style
Malebo, K., Woodward, J., Ximba, P., Mkhize, Q., Cingo, S., Moyo-Gwete, T., Moore, P. L., Williamson, A.-L., & Chapman, R.
(2024). Development of a Two-Component Nanoparticle Vaccine Displaying an HIV-1 Envelope Glycoprotein that Elicits Tier 2 Neutralising Antibodies. Vaccines, 12(9), 1063.
https://doi.org/10.3390/vaccines12091063
